UBS Cuts Price Target on L Brands (LB) to $68 Following 1Q EPS Beat
Get Alerts LB Hot Sheet
Rating Summary:
21 Buy, 21 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
UBS maintained a Neutral rating on L Brands (NYSE: LB), and cut the price target to $68.00 (from $74.00), following the company's 1Q earnings report. LB reported EPS of $0.59, coming in ahead of the Street's $0.55 estimate. However, management lowered '16 guidance to $3.60-3.80 from $3.90-4.10.
Analyst Michael Binetti commented, "LB reported 1Q EPS of $0.59 (vs UBSe/Street: $0.55), but lowered '16 guidance to $3.60-3.80 from $3.90-4.10 based on 1) -$0.20 from recently-decelerating VS SSS and new VS initiatives (like eliminating Swim and clearing inventory); and 2) a -$0.10 drag to invest in the newly acquired China business. FY16 GMs now are anticipated to be worse vs. initial guidance based on worse-than-expected 1Q results (-170bp vs UBSe: -100bp, Street: -90bp) that were hurt by a promotional misstep in April, and higher markdowns through the year from the exit of non-core VS categories (swim, online only shoes/apparel/accessories). LB's revised EPS guidance is below our recently-lowered FY16 estimate (LB Downgrade to Neutral)—at $3.60-$3.80 vs $3.90-$4.10 prev. We're lowering our FY16E EPS to $3.70 from $3.93 (lowered in downgrade from $4.20)."
For an analyst ratings summary and ratings history on L Brands click here. For more ratings news on L Brands click here.
Shares of L Brands closed at $63.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- Allegiant Travel Company (ALGT) PT Raised to $103 at UBS
- Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share